4//SEC Filing
Jacobs Bruce N. 4
Accession 0000950170-25-048049
CIK 0001815442other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 8:00 AM ET
Size
6.8 KB
Accession
0000950170-25-048049
Insider Transaction Report
Form 4
Jacobs Bruce N.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-31$2.08/sh+25,000$52,000→ 226,886 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-31−25,000→ 69,899 totalExercise: $2.08Exp: 2029-08-28→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares vested in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001821074
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 8:00 AM ET
- Size
- 6.8 KB